The Survival Benefit of Kidney Transplantation in Obese Patients

    loading  Checking for direct PDF access through Ovid

Abstract

Obese patients have a decreased risk of death on dialysis but an increased risk of death after transplantation, and may derive a lower survival benefit from transplantation. Using data from the United States between 1995 and 2007 and multivariate non-proportional hazards analyses we determined the relative risk of death in transplant recipients grouped by body mass index (BMI) compared to wait-listed candidates with the same BMI (n = 208 498). One year after transplantation the survival benefit of transplantation varied by BMI: Standard criteria donor transplantation was associated with a 48% reduction in the risk of death in patients with BMI ≥ 40 kg/m2 but a ≥66% reduction in patients with BMI < 40 kg/m2. Living donor transplantation was associated with ≥66% reduction in the risk of death in all BMI groups. In sub-group analyses, transplantation from any donor source was associated with a survival benefit in obese patients ≥50 years, and diabetic patients, but a survival benefit was not demonstrated in Black patients with BMI ≥ 40 kg/m2. Although most obese patients selected for transplantation derive a survival benefit, the benefit is lower when BMI is ≥40 kg/m2, and uncertain in Black patients with BMI ≥ 40 kg/m2.

In this US Renal Data System analysis, the authors show that most obese patients derive a similar survival benefit from transplantation as nonobese patients, but the survival benefit is lower in patients with body mass index ≥ 40 kg/m2, and uncertain in black recipients with body mass index ≥ 40 kg/m2 and black recipients with body mass index of 35.0–39.9 kg/m2 who received expanded criteria donor transplants.

Related Topics

    loading  Loading Related Articles